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An alternative and simple coprecipitation method was developed to obtain carbon nanotube-hydroxyapatite (CNTs:HAp) based
nanocomposites. The incorporation of CNTs (in a concentration of 5% and 10% of total weight of the nanocomposite) and their
impact on both structural and biological properties were studied by using a set of standard complementary biological, microscopic,
and spectroscopic techniques.The characteristic peaks of carbon structure inCNTswere not observed in theCNTs-HAp composites
by X-ray diffraction analysis. Moreover, FTIR and Raman spectroscopies confirmed the presence of HAp as the main phase of the
synthesized CNTs:HAp nanocomposites.The addition of CNTs considerably affected the nanocompositemorphology by increasing
the average crystallite size from 18.7 nm (for raw HAp) to 28.6 nm (for CNTs:HAp-10), confirming their proper incorporation.The
biocompatibility evaluation of CNTs:HAp-5 and CNTs:HAp-10 nanocomposites included the assessment of several parameters,
such as cell viability, antioxidant response, and lipid peroxidation, on human G-292 osteoblast cell line. Our findings revealed good
biocompatibility properties for CNTs:HAp nanocomposites prepared by the coprecipitationmethod supporting their potential uses
in orthopedics and prosthetics.
1. Introduction
One of the major problems that modern medicine has to
face is the development of new materials that can mimic the
human tissue in order to minimize the risk of rejection by
the human body. According to a report of The American
Association of Orthopedic Surgeons in 2002, bone implants
are one of the most common transplants, outranked only by
blood transfusions. In this context, worldwide, researchers
have focused their attention on obtaining new and improved
materials with special properties for hard tissue replacement
implants. For this purpose, they explored the field of bio-
materials. A study has revealed that, in a period of 6 years,
between 2008 and 2014, the biomaterials device market has
increased with almost 150 billion dollars [1, 2]. There are two
main categories of orthopedic biomaterials: implants usually
made of metals, ceramics, or hard polymers and scaffolds for
bone tissue regeneration [1]. The second type of biomaterials
is based on biodegradable polymers and their composites [1].
Themost frequently used biomaterial in orthopedic surgeries
is hydroxyapatite (HAp). Having the chemical composition
Ca
10
(PO
4
)
6
(OH)
2
, hydroxyapatite is found in human bones
and teeth, being the main mineral constituent of natural
hard tissue [3–5]. Given the similarity with the human
tissue, synthetic hydroxyapatite can bond with natural bones
[3]. Furthermore, it has outstanding properties, such as
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a remarkable bioactivity and osteoconductivity, which make
it a suitable candidate for coating metallic implants, creating
an adequate surface for bone growth and integration [1, 6–10].
However, recent studies have emphasized the weaknesses of
HAp implants or coatings, caused by the fragility of synthetic
hydroxyapatite, its low fracture toughness, wear resistance
[1, 7–9, 11, 12], the appearance of corrosion, and negative
tissue reaction. All these drawbacks can induce loosening
of implants. Therefore, in order to improve the mechanical
properties of HAp and to increase the corrosion resistance,
its structuremust be reinforced withmaterials such as carbon
nanotubes (CNTs), TiO
2
, or ZrO
2
[13–19]. Since the discovery
of CNTs in 1991 by Iijima [20], they have been studied
intensively due to their extraordinary thermal, electrical, and
mechanical properties owed to their unique atomic structure
[21–23]. Previous studies have proven that CNTs are some
of the toughest materials discovered. Compared to steel, the
tensile strength of carbon nanotubes is one hundred times
higher, although the density is almost seven times lower than
the density of steel [24, 25]. Another remarkable property
is the resistance of CNTs to erosion. They can withstand
exposure to strong acids and alkali without having their struc-
ture affected [24, 26–28]. Moreover, the biocompatibility of
CNTs in orthopedic applications by in vitro studies has been
established, which showed an accelerated bone growth [1, 29].
Also, several studies [1, 30–33] have proven that carbon nan-
otubes induced increased proliferation and differentiation of
osteoblasts in vitro. Although the biocompatibility of CNTs
was not unanimously recognized due to the contradictory
reports, it has been shown that different ceramics or polymer
matrices reinforced with carbon nanotubes improve the
structural properties, like fracture toughness, strength, elastic
modulus, or wear resistance [1, 34–36] without jeopardizing
the properties of the reinforced material.
In this study, we report the synthesis of CNTs:HAp
nanocomposites at low temperature by a simple technique.
The phase and the chemical structures of the prepared
samples were tested by X-ray diffraction, Fourier transform
infrared (FTIR), and Raman spectroscopies. Moreover, the
structure of the CNTs:HAp-5 and CNTs:HAp-10 nanocom-
positeswas analyzed by scanning electronmicroscopy (SEM).
Furthermore, the human G-292 osteoblast-like cell line
was selected as an in vitro model to assess CNTs:HAp
nanotoxicity and biological properties. In order to test the
biocompatibility of carbon nanotubes-hydroxyapatite based
nanocomposites, several parameters including cell viability,
antioxidant response, and lipid peroxidation were assessed.
2. Materials and Methods
2.1. Chemicals. The reagents used for the synthesis of
hydroxyapatite were ammonium dihydrogen phosphate
[(NH
4
)
2
HPO
4
] (Alpha Aesare, Germany, 99.99% purity),
calcium nitrate [Ca(NO
3
)
2
⋅4H
2
O] (Alpha Aesare, Germany,
99.99% purity), and ammoniumhydroxide [NH
4
OH] (Alpha
Aesare, Germany, 99.99% purity).
2.2. Preparation of Carbon Nanotubes. The chemical vapor
deposition (CVD) method was used to grow single-wall
CNTs onto a quartz substrate. The CVD method synthesis
is essentially a two-step process consisting of a catalyst
preparation step followed by the actual synthesis of the CNTs.
The quartz piece cut into required dimensions was first heat
treated in a furnace at 500∘C for about 10 minutes. It was
then cooled down to the room temperature and dipped in
the catalyst that was basically a solution of ethanol and Fe-
Mo in mole ratio of 10 : 1. The quartz substrate thus dipped in
catalyst was then placed in a quartz tube in a CVD furnace.
The deposited Fe catalyst was then reduced at 800∘C by using
hydrogen and argon gases which passed through the furnace.
Finally, the substrate was subjected to a source of carbon by
the passing of ethylene gas that caused the decomposition of
carbon and resulted in the synthesis of CNTs.
2.3. Preparation of Hydroxyapatite-Carbon Nanotube Com-
posite. The synthesis of carbon nanotubes-hydroxyapatite
(CNTs:HAp) nanocomposites was achieved by an adapted
coprecipitation method. Ca(NO
3
)
2
⋅4H
2
O was dissolved in
300mL deionized water. Then, a quantity of 0.5 g or 1 g of
CNTs was added into the Ca(NO
3
)
2
⋅4H
2
O solution and was
sonicated for 12 hours to obtain a homogeneous mixture. On
the other hand, the (NH
4
)
2
HPO
4
was dissolved in 300mL
deionized water according to the molar ratio of Ca/P 1 : 67.
The (NH
4
)
2
HPO
4
solution was added drop by drop into the
[CNTs + Ca(NO
3
)
2
⋅4H
2
O] homogeneous mixture with con-
tinuous stirring at 50∘C for 12 hours. The pH was constantly
adjusted and kept at 10 with ammonia solution during the
reaction. The resulting mixture was washed several times
with deionized water maintaining a neutral pH to remove
the residual NO
3
− and NH
4
+. The resulting CNTs:HAp-5
(0.5 g of CNTs added into the Ca(NO
3
)
2
⋅4H
2
O solution) and
CNTs:HAp-10 (1 g of CNTs added into the Ca(NO
3
)
2
⋅4H
2
O
solution) nanocomposite samples were dried at 80∘C for 48
hours in an oven. Furthermore, the synthesis of hydroxya-
patite (HAp; Ca
10
(PO
4
)
6
(OH)
2
) was carried out as reported
[37, 38] by the following reaction [39]:
10Ca (NO
3
)
2
⋅ 4H
2
O + 6 (NH
4
)
2
HPO
4
+ 2NH
4
OH
󳨀→ Ca
10
(PO
4
)
6
(OH)
2
+ 20NH
4
NO
3
+ 46H
2
O
(1)
2.4. Sample Characterization. X-ray diffraction characteri-
zation was carried out using a Bruker D8 Advance diffrac-
tometer, with nickel filtered CuK
𝛼
(𝜆 = 1.5418 A˚) radiation
with a high efficiency one-dimensional detector (Lynx Eye
type) operated in integration mode. The diffraction patterns
were collected in the 2𝜃 range 20∘–90∘, with a step of 0.02∘
and 34 seconds measuring time per step. A Perkin Elmer
1720X FTIR spectrometer was used for all spectroscopic
studies.The instrument was equippedwith a horizontal ATR-
FTIR accessory from Spectra-Tech. All the spectra were the
results of 256 coadded scans at a resolution of 4 cm−1 and a
spectral range of 500–2000 cm−1. All of the FTIR analyses
were conducted at room temperature around 23∘C. The
spectrumwas recorded in the range of 500 to 4000 cm−1 with
4 cm−1 resolution. Micro-Raman spectra on powders were
performed in a backscattering geometry at room temperature
and in ambient air, under a laser excitation wavelength of
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514 nm, using a Jobin Yvon T64000 Raman spectrophotome-
ter placed under a microscope. The morphology of the HAp,
NTCs, NTCs:HAp-5, and NTCs:HAp-10 was analyzed by
SEM (HITACHI S2600N microscope).
2.5. Cell Culture and Treatment. G-292 osteoblast cell line
(ATCC CRL-1423) derived from human osteosarcoma was
cultured inMcCoy’s 5Amedium (Gibco, USA) supplemented
with 1.5mM L-glutamine, 2.2 g/L sodium bicarbonate, peni-
cillin (100U/mL), streptomycin (100 𝜇g/mL), and 10% fetal
bovine serum (Gibco, USA). Cells were grown in 25 cm2
flasks and incubated at 37∘C in a humidified atmosphere with
5% CO
2
, while the medium was replaced every 2 to 3 days.
Cells were detached for subcultivation using 0.25% trypsin-
0.53mM EDTA solution. The osteoblasts were counted and
distributed at a density of 2 × 104 cells/cm2 into 96-well
plates or 25 cm2 flasks and incubated at 37∘C in a humidified
atmosphere with 5% CO
2
to allow cell adhesion overnight.
Afterwards, cells were exposed to various concentrations
(0.25, 2.5, 25, 100, and 500𝜇g/mL) ofCNTs,HAp,CNTs:HAp-
5, and CNTs:HAp-10 for 24 and 48 hours.
2.6.MTTAssay. Cell viability was evaluated byMTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) col-
orimetric assay. After 24 and 48 hours of exposure to CNTs,
HAp, and CNTs:HAp-5 and CNTs:HAp-10 nanocomposites,
the medium was removed and the cells were washed with
PBS and incubated with 1mg/mL MTT solution for 2 hours
at 37∘C. Afterwards, the MTT solution was removed and
the purple intracellular formazan crystals were solubilized
with isopropanol.The absorbance was read at 595 nm using a
Tecanmultiplate reader (TECANGENios, Gro¨dic, Germany)
and the optical density for untreated cells was represented
as a viability of 100%. In spite of all controversies in using
the MTT assay to test cytotoxicity of CNTs and to determine
relative cell viability, we did not observe any interference of
CNTs with the MTT assay, or any indication of false results,
which is supported by previous studies on CNTs [40, 41].
2.7. Glutathione Assay. At the end of exposure, cells were
detached and total protein extract was obtained by sonication
(3 times × 30 seconds on ice) using an ultrasonic processor
(Hielscher UP50H, Germany). The cell lysate was further
deproteinized with a 5% sulfosalicylic acid (1 : 1), centrifuged
at 10,000 rpm for 10 minute at 4∘C. The cellular GSH con-
centration was determined using the Glutathione Assay Kit
(Sigma-Aldrich, USA) following the protocol provided by
the manufacturer. Briefly, each sample was incubated with
5,5󸀠-dithiobis-2-nitrobenzoic acid (DTNB) for 5 minutes at
room temperature in order to allow the reduction of DTNB
into 5-thio-2-nitrobenzoic acid (TNB). The absorption was
recorded at 405 nm using a Tecan multiplate reader (TECAN
GENios, Gro¨dic, Germany). The GSH levels were calculated
as nmoles GSH/mg protein and the results were expressed
relative to control.
2.8. Malondialdehyde Assay. Malondialdehyde (MDA) con-
centration was assessed according to the method described
by Dinischiotu et al. [42]. A volume of 200 𝜇L of sample
diluted correspondingly was mixed with 700𝜇L of 0.1 N HCl
and incubated for 20 minutes at room temperature. Then,
900 𝜇L of 0.025M thiobarbituric acid (TBA) was added and
the totalmixturewas incubated for 65min at 37∘C.TheMDA-
TBA adduct fluorescence was measured using a JASCO FP-
6300 spectrofluorometer (𝜆ex/𝜆em of 520 nm/549 nm). The
MDA concentration was calculated using a standard curve of
1,1,3,3-tetramethoxypropane in the range of 0.05–5 𝜇M and
expressed as nmoles of MDA/mg protein. The results were
represented relative to control.
2.9. Protein Concentration Assay. The protein concentration
of the cellular extract was determined by Bradford method
[43] using bovine serum albumin as standard.
2.10. Statistical Analysis. All values are expressed as mean
value ± standard deviation (SD) of three independent exper-
iments. The data was analyzed for statistical difference by
Student’s t-test. A 𝑝 value less than 0.05 was considered
significant.
3. Results and Discussion
3.1. Characterization of Carbon Nanotubes and Hydroxya-
patite Composite Materials. X-ray diffraction patterns of
pure HAp and CNTs:HAp (CNTs:HAp-5 and CNTs:HAp-
10) nanocomposites in the 2𝜃 ranges 20∘–90∘ and 20∘–
30∘, respectively, are shown in Figure 1. The characteris-
tic diffraction pattern of CNTs:HAp-5 and CNTs:HAp-10
nanocomposites shows a similar behavior of the spectrum
for pure HAp (Figure 1(b)). The peak observed at 2𝜃 =
26.38
∘, characteristic to CNTs, made no contribution to the
specific peak of hydroxyapatite (2𝜃 = 25.84∘), which shows
that the peaks corresponding to the addition of CNTs did
not appear. It can also be seen that the diffraction peaks of
CNTs:HAp composites are in agreement with those of pure
HAp indexed to the hexagonal Ca
10
(PO
4
)
6
(OH)
2
in 𝑃
63m
space group (ICDD-PDF number 9-432).
The average sizes 𝐷 of HAp and CNTs:HAp were calcu-
lated from the XRD patterns using Scherrer’s formula [44]:
𝐷 = 𝐾𝜆/𝐵 cos 𝜃, where 𝐾 is a constant (shape-factor) whose
value is 0.9, 𝜆 is the wavelength of X-rays (1.5406 A˚), 𝐵 (in
rad) is the full width at half maximum (FWHM), and 𝜃 is the
Bragg angle.The grain size increased from 18.7±1 nm (HAp)
to 22.5±1 nm (CNTs:HAp-5) and to 28.6±1 nm (CNTs:HAp-
10).
In good agreement with previous studies [45], the XRD
patterns of HAp and CNTs:HAp composites demonstrate
that the powders exhibit the apatite characteristics with good
crystal structure and no new phase or impurity was found.
The phase and the chemical structures of the CNTs:HAp
nanocomposite were analyzed by FTIR and Raman spectro-
scopies. The ATR-FTIR technique was used to investigate
the CNTs:HAp nanocomposites. Figure 2 shows the ATR-
FTIR spectra of pure HAp, CNTs:HAp-5, and CNTs:HAp-
10 nanocomposites. It has been reported that the vibra-
tion peaks at 1645 cm−1 correspond to H–O–H bands of
water lattice [37]. The band at 630 cm−1 characteristic to
4 Journal of Nanomaterials
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Figure 1: Comparative representation of the experimental XRD patterns of the HAp and CNTs:HAp-5 and CNTs:HAp-10 nanocomposites
in the 2𝜃 ranges 20∘–90∘ (a) and 20∘–30∘ (b), respectively.
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Figure 2: FTIR-ATR spectra of the pure HAp and CNTs:HAp-5 and CNTs:HAp-10 nanocomposites.
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the stretching vibrational mode of [OH]− was present in
both HAp and CNTs:HAp (CNTs:HAp-5 and CNTs:HAp-
10) composites spectra and indicated a well-crystallized HAp
[46, 47]. According to previous studies conducted by Yang et
al. [48] and Pan et al. [49], the band at 1095 cm−1 suggests also
the formation of a well-crystallized apatite.
On the other hand, the bands at 600 cm−1 and 560 cm−1
appearing from ]
4
[PO
4
]3− and indicated also a well-
crystallized HAp [47]. The band at 962 cm−1 is due to ]
1
[PO
4
]3− mode of phosphates while the bands at 1015 cm−1
and 1095 cm−1 can be attributed to the ]
3
[PO
4
]3− mode of
phosphates [50, 51]. According to Ciobanu et al. [37, 46],
the characteristic bands for carbonate at 878 and 1421 cm−1
are probably due to the combination of ]
2
-out-of-plane
bend vibration and ]
3
-asymmetric stretching vibration. In
the ATR-FTIR spectra, the bands of phosphates and the
carbonate were observed for all samples. The characteristic
peak of CNTs at 2359 cm−1 reported in literature by Niu et al.
[52] was not observed in the CNTs:HAp nanocomposites. On
the other hand, the bands around 2919 cm−1 and 2852 cm−1
which are due to the asymmetric and symmetric stretching
of C–H bonds reported by Krishna Kumar et al. [53] were
not observed in the NTCs:HAp nanocomposites spectra.The
FTIR spectra of CNTs:HAp-5 and CNTs:HAp-10 nanocom-
posites exhibited similar peaks to those of pure HAp except
for the peak at 1335 cm−1 which appeared in CNTs:HAp-10
nanocomposites spectrum.According toWahab et al. [54] the
peak at around 1335 cm−1 is characteristic to the vibrational
mode of carbonate ions in hydroxyl sites. Following these
investigations, we can say that the presence of CNTs in
the CNTs:HAp nanocomposites does not change the basic
structure of HAp.
The proper formation of CNTs:HAp nanocomposites was
confirmed through Raman scattering. Figure 3 shows the
Raman spectra ofHAp, CNTs, CNTs:HAp-5, andCNTs:HAp-
10 composites.
The vibrational bands attributed to asymmetric ]
3
(P–O)
stretching [37] are observed at the wavenumbers of 1045 cm−1
(]
3
) and 1075 cm−1 (]
3
) for raw HAp while they shift to
lower wavenumber at 1042 cm−1 (]
3
) and 1070 cm−1 (]
3
)
for CNTs:HAp-5 and CNTs:HAp-10 nanocomposites, respec-
tively. The proper incorporation of CNTs was confirmed by
6 Journal of Nanomaterials
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Figure 4: SEM images of pure HAp (a), CNTs (b), and CNTs:HAp-5 (c) and CNTs:HAp-10 (d) nanocomposites.
the presence of two common bands, in the region 1300–
1600 cm−1 for both the CNTs:HAp-5 and CNTs:HAp-10
spectra, related to the D and G bands. For bulk CNTs, these
bands that underline the degree of crystallinity and order in
the graphitization process appear at 1345 cm−1 and 1572 cm−1.
Once CNTs were mixed with HAp, these bands shifted to
lower frequencies at 1355 cm−1 and 1580 cm−1 for the D and
G bands, respectively. Previous studies [55–57] showed that
the peaks at 1580 cm−1 (in CNTs spectrum) and 1575 cm−1
(in CNTs:HAp-5 andCNTs:HAp-10 nanocomposites spectra)
were associated with the tangential displacement of C–C
band stretching mode of the well-graphitized nanotubes.
On the other hand, the peaks at 1355 cm−1 (in CNTs
spectra) and 1345 cm−1 (in CNTs:HAp-5 and CNTs:HAp-10
nanocomposite spectra) were associated with the vibration of
carbon atoms in the disorder mode. Comparing the D-mode
and G-mode of CNTs and CNTs:HAp-5 and CNTs:HAp-10
nanocomposites, a little change in the frequency value was
observed which can be associated with an increase in the
defect density of graphite after being mixed into HAp [58].
The nanostructure and morphology of pure HAp, CNTs,
and CNTs:HAp-5 and CNTs:HAp-10 nanocomposites were
studied by SEM (Figure 4). The SEM images of CNTs:HAp-
5 and CNTs:HAp-10 revealed that the nanoparticles were
uniformly distributed without forming any agglomeration.
The CNTs packages have been destroyed as a result of the
formation of CNTs:HAp nanocomposite.
In previous studies, Zheng et al. [59] showed that the
CNTs tended to aggregate in water due to the van der Waals
interactions. Compared to pure and nonfunctionalized CNTs
samples presented in Figure 4, the CNTs:HAp nanocompos-
ite could be dispersed well due to the presence of HAp.
3.2. Biochemical Studies. As it can be observed from
Figure 5(a), a dose-dependent decrease in cell viability was
registered for CNTs treated cells after 24 hours of exposure,
whereas HAp stimulated cell proliferation confirming its
biocompatibility effect. At the same time, the cell viability for
low doses of CNTs:HAp-5was not significantly changed (only
a 10%decrease for 25 𝜇g/mL comparedwith control). Regard-
ing the highest doses (100 𝜇g/mL and 500𝜇g/mLCNTs:HAp-
5), the viability was diminished by 17% and 20%, respectively,
compared to the control. Exposure to CNTs:HAp-10 induced
a decreased viability only for doses higher than 2.5𝜇g/mL (a
28% decrease for the concentration of 500𝜇g/mL compared
to control).
Further, our results (Figure 5(b)) showed that CNTs
exhibited a higher cytotoxicity after 48-hour exposure
Journal of Nanomaterials 7
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Figure 5: Cell viability after 24 (a) and 48 (b) hours of exposure to NTCs, HAp, and CNTs:HAp-5 and CNTs:HAp-10. Values are calculated
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Figure 6: GSH levels in G-292 cells exposed to CNT,HAp, and CNTs:HAp-5 and CNTs:HAp-10 at concentrations of 25𝜇g/mL and 100 𝜇g/mL
for 24 and 48 hours. Values are calculated as means ± SD (𝑛 = 3) and expressed relative to control. ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01 versus control.
compared to 24-hour one and the cell viability was slightly
decreased compared to control after the incubation with
HAp. CNTs:HAp-5 nanocomposites stimulated cell prolif-
eration in a dose-dependent manner suggesting a higher
biocompatibility compared with CNTs:HAp-10 nanocom-
posites which were more toxic at higher doses (100 𝜇g/mL
and 500 𝜇g/mL). The significant increase of cell viability for
CNTs:HAp-5 after 48 hours could be explained by the fact
that there is a time interval necessary for osteoblasts to adapt
to the environment created by the nanocomposites.
Humans are well equipped with an excellent antioxidant
system to fight against oxidative stress induced by a various
number of damaging effects, protecting efficiently against the
formation of free radicals. Thus, being the most prevalent
endogenous intracellular thiol antioxidant, GSH plays a
central role in neutralizing free radicals and reactive oxygen
species.
After 24 hours, a dose-dependent increase of GSH level
was noticed in the cells exposed to simple CNTs, whereas a
decrease was observed at 48 hours of treatment, suggesting
the CNTs toxicity (Figure 6). Regarding the incubation with
CNTs:HAp nanocomposites, the GSH content was near to
the control values and HAp levels after the first 24 hours
diminished only by 20% compared with control for the high-
est dose, proving their biocompatibility.The above results are
similar to the studies performed by Patel and Kwon [60], in
which higher GSH levels were observed after 24 hours of
treatment and lower values after 48 hour exposure of A549
epithelial cells to multiwalled carbon nanotubes (MWCNTs).
The initial increase could be due to a higher demand of GSH
to combat the rapid formation of reactive oxygen species
(ROS), followed by the depletion of this tripeptide that was
rapidly consumed in the resulted oxidative stress.
The level of MDA was determined as a marker of lipid
peroxidation in G-292 cells exposed to 25 and 100 𝜇g/mL of
CNTs, HAp, CNTs:HAp-5, and CNTs:HAp-10 (Figure 7).
After both time intervals of incubation with simple CNTs
or CNTs:HAp nanocomposites, MDA contents increased in
a dose- and time-dependent manner compared with the
control, but the peroxidation for nanocomposites was below
the CNTs level. Thus, the nanocomposites showed a lower
toxicity compared to CNTs, suggesting their biocompatibility
on human osteoblasts through the presence of HAp. In
the case of pure HAp exposure, the MDA levels were near
the control values, suggesting the absence of hydroxyapatite
toxicity. In addition, the oxidative stress induced by CNTs
8 Journal of Nanomaterials
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Figure 7: MDA levels in G-292 cells exposed to CNTs, HAp, and CNTs:HAp-5 and CNTs:HAp-10 at concentrations of 25𝜇g/mL and
100𝜇g/mL for 24 and 48 hours. Values are calculated as means ± SD (𝑛 = 3) and expressed relative to control. ∗𝑝 < 0.05 versus control.
correlated very well with the decreased cell viability observed
in Figure 5.
4. Conclusions
In this study, we obtained CNTs:HAp nanocomposites
through a simple adapted coprecipitationmethod, which was
followed by a characterization of chemical, structural, and
biological properties in order to establish their biocompati-
bility on human osteoblasts. XRD analysis results revealed a
good crystal structure, without any peaks corresponding to
the addition of CNTs or impurities. Comparing the D-mode
and G-mode of CNTs and CNTs:HAp composites, a minor
change in the frequency value was observed. All biochemical
parameters investigated with the help of in vitro methods
presented a variation dependent on time and concentration.
Taken together, low doses of CNTs doped hydroxyapatite
nanocrystalline powders did not significantly decrease G-292
cell viability and did not induce oxidative stress after 2 days of
exposure.These results support the applicability of CNT:HAp
nanocomposites prepared by the coprecipitation method for
medical purposes because they exhibit good biocompatibility
and have great potential in the future for orthopedics and
prosthetics.
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